azimilide has been researched along with Myocardial Infarction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pratt, CM | 1 |
| Marcello, SR; Pritchett, EL | 1 |
| Al-Khalidi, HR; Brum, JM; Camm, AJ; Holroyde, MJ; Karam, R; Pratt, CM; Schwartz, PJ; Sonnenblick, EH; Spyt, MJ | 1 |
| Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J | 1 |
| Black, SC; Butterfield, JL; Lucchesi, BR | 1 |
| Brooks, RR; Drexler, AP; Micklas, JM | 1 |
| Camm, AJ; Karam, R; Pratt, CM | 1 |
| Boyden, PA; Cabo, C; Jiang, M; Tseng, G; Yao, J | 1 |
| Cabo, C; Coromilas, JC; Schmitt, H; Wit, AL | 1 |
| SoRelle, R | 1 |
2 review(s) available for azimilide and Myocardial Infarction
| Article | Year |
|---|---|
Pure class III agents for prevention of sudden cardiac death.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Death, Sudden, Cardiac; Europe; Humans; Hydantoins; Imidazoles; Imidazolidines; Middle Aged; Myocardial Infarction; Phenethylamines; Piperazines; Randomized Controlled Trials as Topic; Sotalol; Sulfonamides; Survival Analysis; Treatment Outcome | 2003 |
Azimilide for atrial fibrillation: clinical trial results and implications.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Humans; Hydantoins; Imidazoles; Imidazolidines; Myocardial Infarction; Piperazines; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
2 trial(s) available for azimilide and Myocardial Infarction
| Article | Year |
|---|---|
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Double-Blind Method; Female; Heart Rate; Humans; Hydantoins; Imidazoles; Imidazolidines; Life Tables; Male; Middle Aged; Myocardial Infarction; Neutropenia; Piperazines; Potassium Channel Blockers; Risk Factors; Survival Analysis; Torsades de Pointes; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
The azimilide post-infarct survival evaluation (ALIVE) trial.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Myocardial Infarction; Piperazines; Risk Factors; Stroke Volume; Survival Rate | 1998 |
6 other study(ies) available for azimilide and Myocardial Infarction
| Article | Year |
|---|---|
The influence of extracellular acidosis on the effect of IKr blockers.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; Hydantoins; Imidazolidines; Myocardial Infarction; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Trans-Activators; Xenopus laevis | 2005 |
Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Topics: Animals; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Heart Rate; Hydantoins; Imidazoles; Imidazolidines; Male; Myocardial Infarction; Piperazines; Piperidines; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Dogs; Electrocardiography; Heart; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Infusions, Intravenous; Male; Myocardial Infarction; Piperazines; Sotalol | 1996 |
Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle.
Topics: Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Dogs; Electrophysiology; Hydantoins; Imidazoles; Imidazolidines; Myocardial Infarction; Myocardium; Nisoldipine; Patch-Clamp Techniques; Piperazines; Potassium Channels; RNA, Messenger; Sodium; Sodium-Potassium-Exchanging ATPase; Time Factors | 2000 |
Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Hydantoins; Imidazoles; Imidazolidines; Male; Models, Animal; Myocardial Infarction; Piperazines; Tachycardia, Ventricular; Ventricular Fibrillation | 2001 |
Cardiovascular news.
Topics: Acetanilides; Angina, Unstable; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Fondaparinux; Humans; Hydantoins; Imidazoles; Imidazolidines; Multicenter Studies as Topic; Myocardial Infarction; Nicorandil; Piperazines; Polysaccharides; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2001 |